RE: Location Poll #2Cambridge, Ont.
Heard about ONC via some consultant report on the state of CDN biotech. It spoke positively of my core holding (IDB) and also mentioned ONC. I needed to diversify my biotech holdings from IDB (which has been a home run so far this year) that I plan on exiting within the next two years. Investigated ONC and science seems unique and interesting. Bought a few thousand shares between 3.50 and 4.00. Will add significantly if management can deliver anything, which in my estimation is the big weakness and the huge question mark of this company. Lots of time to add to position if management proves it has the capabilities to grow the business.